Literature DB >> 21051042

Evaluation of an anion-exchange hollow-fiber membrane adsorber containing γ-ray grafted glycidyl methacrylate chains.

Hironobu Shirataki1, Chie Sudoh, Takamitsu Eshima, Yoshiro Yokoyama, Kazuo Okuyama.   

Abstract

It is widely recognized that membrane adsorbers are powerful tools for the purification of biopharmaceutical protein products and for this reason a novel hollow-fiber AEX type membrane adsorber has been developed. The membrane is characterized by grafted chains including DEA ligands affixed to the pore surfaces of the membrane. In order to estimate the membrane performance, (1) dynamic binding capacities for pure BSA and DNA over a range of solution conductivity and pH, (2) virus reduction by flow-through process, and (3) HCP and DNA removal from cell culture, are evaluated and compared with several other anion-exchange membranes. The novel hollow-fiber membrane is tolerant of high salt concentration when adsorbing BSA and DNA. When challenged with a solution containing IgG the membrane has high impurity removal further indicating this hollow-fiber based membrane adsorber is an effective tool for purification of biopharmaceutical protein products including IgG.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051042     DOI: 10.1016/j.chroma.2010.10.071

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Representative mammalian cell culture test materials for assessment of primary recovery technologies: a rapid method with industrial applicability.

Authors:  Daria Popova; Adam Stonier; David Pain; Nigel J Titchener-Hooker; Suzanne S Farid
Journal:  Biotechnol J       Date:  2015-01       Impact factor: 4.677

2.  Integrated economic and experimental framework for screening of primary recovery technologies for high cell density CHO cultures.

Authors:  Daria Popova; Adam Stonier; David Pain; Nigel J Titchener-Hooker; Suzanne S Farid
Journal:  Biotechnol J       Date:  2016-05-09       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.